STVN (Stevanato Group SpA) Moat Score: 6/10 (As of Sep. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STVN Stevanato Group SpA STVN
86 GF Score
Price $20.32
GF Value $26.04
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Stevanato Group SpA Moat Score?

Stevanato Group SpA STVN -0.93% 86 Moat Score is 6 as of Sep. 09, 2026. GuruFocus rates STVN with a GF Score™ of 86/100 and a GF Value™ of $26.04 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 833 Medical Devices & Instruments companies, Stevanato Group SpA ranks better than 95.68% on this metric.

Stevanato Group SpA has the Moat Score of 6, which implies that the company might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Stevanato Group SpA has Narrow Moat: Stevanato Group SpA has a strong narrow moat due to its leadership in pharmaceutical packaging and proprietary technology. It benefits from economies of scale and a robust distribution network, but lacks the regulatory barriers and customer switching costs needed for a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Stevanato Group SpA might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.


Stevanato Group SpA  (NYSE:STVN) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Stevanato Group SpA Moat Score Related Terms


STVN vs MMED, TFX, MMSI: Moat Score Comparison

For the Medical Instruments & Supplies subindustry, Stevanato Group SpA's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stevanato Group SpA Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stevanato Group SpA's Moat Score distribution charts can be found below:

* The bar in red indicates where Stevanato Group SpA's Moat Score falls into.


STVN
86GF Score
Stevanato Group SpA STVN
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 6 mean?
Stevanato Group SpA (STVN) has a Moat Score of 6 as of Sep. 09, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Stevanato Group SpA ranks #36 out of 833 companies in the Medical Devices & Instruments industry, placing it in the top 4.3%.
Is Stevanato Group SpA's Moat Score too high?
Stevanato Group SpA's current Moat Score is 6. Based on the distribution chart, Stevanato Group SpA ranks #36 out of 833 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Stevanato Group SpA has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Stevanato Group SpA's Moat Score compare to MMED and TFX?
According to the Medical Devices & Instruments industry distribution chart, Stevanato Group SpA ranks #36 out of 833 companies for Moat Score. This places Stevanato Group SpA in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Stevanato Group SpA's current Moat Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stevanato Group SpA stock overvalued right now?
Based on GuruFocus' analysis, Stevanato Group SpA (STVN) is currently considered Modestly Undervalued. The stock's GF Value™ is $26.04, compared to a current price of $20.32 — trading 22% below its estimated fair value. The current Moat Score is 6. Stevanato Group SpA's overall GF Score™ is 86/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Stevanato Group SpA (STVN), the current Moat Score is 6 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stevanato Group SpA (STVN) Overvalued in 2026?

Based on GuruFocus' analysis, Stevanato Group SpA stock appears to be undervalued. The current stock price of $20.32 is trading 22% below its estimated GF Value™ of $26.04. GuruFocus considers Stevanato Group SpA to be Modestly Undervalued.

Key valuation signals for STVN:

  • Moat Score: 6
  • GF Value™: $26.04 vs. price of $20.32 (22% below fair value)
  • GF Score™: 86/100 with 6 warning signs

No single metric tells the full story. See the STVN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Stevanato Group SpA Business Description

Other Exchanges 87N:Germany
Address Via Molinella 17, Piombino Dese, Padua, ITA, 35017
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
86GF Score

Get the complete analysis for STVN

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.32
Price
$26.04
GF Value